In order to assess whether INHBA/ActA-mediated angiocrine is involved in the pathogenesis of PAH in clinical settings, the expression and production of INHBA/ActA were examined using ECs isolated from the lungs of patients with iPAH or normal control subjects. Here, INHBA is linked to pulmonary arterial hypertension.